LED Dental Names Nick Efthimiadis VP Global Sales and Marketing

BURNABY, British Columbia, February 21, 2011—LED Dental Inc. announced today the hiring of Nick Efthimiadis as VP Global Sales and Marketing, effective immediately.  Mr. Efthimiadis joins LED approximately two months after the North American launch of its VELscope Vx Enhanced Oral Assessment system, a cordless, affordably priced instrument that helps dental practices screen patients for oral cancer and other oral disease.

Mr. Efthimiadis brings 15 years of sales and marketing experience, primarily involving dental and medical devices, to LED Dental. Most recently, he served as Senior Product Manager for the market-leading Midwest™ brand at Dentsply International’s Professional Division, where he had full global P&L responsibility. Prior to that, Mr. Efthimiadis was the National Sales Manager for the Prosthetic Division of Dentsply Canada Ltd.  A native of Mississauga, Ontario, he is a 1996 graduate of York University.

“Throughout his career, Nick has shown himself to be an innovative, results-driven marketing, product management and sales leader,” said Peter Whitehead, founder and CEO of LED Dental and its parent company, LED Medical Diagnostics Inc.  “His demonstrated expertise in recruiting, developing and leading world-class teams focused on profitable growth makes him the ideal person to lead our sales and marketing efforts at LED Dental.” Importantly, Mr. Efthimiadis has extensive experience in collaborating with Henry Schein Dental, which was recently named the exclusive North American distributor for LED Dental’s VELscope Vx system.

As the Vice President of Global Sales and Marketing for LED Dental, Mr. Efthimiadis will develop and direct the execution of the company’s product development, marketing strategy and sales plan, and will oversee all sales and marketing activities, personnel and global partnerships.

About LED Dental
LED Dental Inc. is a wholly-owned subsidiary of LED Medical Diagnostics Inc., which was founded in 2003 and is headquartered in Burnaby, British Columbia, Canada. For more information, call   +1 (604) 434-4614, or visit www.VELscope.com.

LED Medical Diagnostics Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995
The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward-looking statements.  Certain information included in this press release (as well as information included in oral statements or other written statements made or to be made by the company) contains statements that are forward-looking, such as statements relating to anticipated future revenues of the company and success of current product offerings.  Such forward-looking information involves important risks and uncertainties that could significantly affect anticipated results in the future and, accordingly, such results may differ materially from those expressed in any forward-looking statements made by or on behalf of the company.  For a description of additional risks and uncertainties, please refer to the company’s filings with the Securities and Exchange Commission.